Brain Cancer Diagnostics Market Forecast to 2028

1
Brain Cancer Diagnostics Market 
Brain Cancer Diagnostics Market Forecast to 2028
- COVID-19 Impact and Global Analysis By
Diagnostic Type (Imaging Test MRI, CT Scan, PET,
and Others, Lumbar Puncture, Biopsy, Molecular
Testing, Platform and Services Sample Slide,
Autosampler Unit, Solutions Platform, and
Services, Cerebral Arteriogram, Neurological
Hearing Tests/Neurocognitive Assessments,
Electroencephalography (EEG), and Others) Cancer
Type (Acoustic Neuroma, Astrocytomas,
Craniopharyngiomas, Ganglioneuromas, Glioblastoma
Multiforme, Meningiomas, Ependymomas,
Oligodendroglioma, Low-Grade Tumors, and Others)
End User (Hospitals, Specialty Clinics,
Ambulatory Surgical Centers, Diagnostic Centers
Research Institutes, and Others) and Tumor Size
(0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, and
Above 200 cm3)
2
Current and future Market Scenario
Brain Cancer Diagnostics Market 
The brain cancer diagnostics market is projected
to reach US 7,378.57 Million by 2028 from US
1,639.10 Million in 2022 it is estimated to grow
at a CAGR of 28.5 from 2022 to 2028.
3
Market Segments
Brain Cancer Diagnostics Market   
Cancer Type Acoustic Neuroma Astrocytomas Cranioph
aryngiomas Ganglioneuromas Ependymomas
Diagnostic Type Imaging Test Cerebral
Arteriogram Neurological Hearing
Tests Electroencephalography (EEG) Others
End User Hospitals Specialty Clinics Ambulatory
Surgical Centers Diagnostic Centers Research
Institutes Others
4
Leading Players
Brain Cancer Diagnostics Market  
Company Profiles in Brain Cancer Diagnostics
Market are THERMO FISHER SCIENTIFIC INC Siemens
Healthineers AG GE Healthcare MDxHealth NantOmics
Biocept, Inc. Koninklijke Philips N.V. Canon
Medical Systems Hitachi, Ltd.
5
Brain Cancer Diagnostics Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/brain-c
ancer-diagnostics-market
Thank You!

• Thank You!